AMGN34:BVMF
Amgen Inc. BDR
R$ ७१.७५
arrow_downward
-०.३५%(-०.२५) 1D
अक्टोबर ६, १६:५६:०० GMT-३ · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AMGN34...
Open
R$ ७१.४८
High
R$ ७१.७५
Low
R$ ७१.४८
Mkt. cap
२.१८ खरब
Avg. vol.
४०५.००
Volume
२००.००
52-wk high
R$ ८३.०६
52-wk low
R$ ४७.७६
Shares outstanding
५४.०६ करोड
No. of employees
३२ हजार
Open
R$ ७१.४८
High
R$ ७१.७५
Low
R$ ७१.४८
Mkt. cap
२.१८ खरब
Avg. vol.
४०५.००
Volume
२००.००
52-wk high
R$ ८३.०६
52-wk low
R$ ४७.७६
Shares outstanding
५४.०६ करोड
No. of employees
३२ हजार
News stories
From web sources and news partners
MarketBeat
·
३ घण्टा पहिले
3,524 Amgen Inc. $AMGN Shares Sold by Colton Groome Financial Advisors LLC
TipRanks
·
३ घण्टा पहिले
Amgen’s AMG 513 Obesity Trial Reaches Phase 1 Completion, Adding a New Angle to the Weight-Loss Drug Race
Yahoo Finance UK
·
८ घण्टा पहिले
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
Profile
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
About Amgen Inc. BDR
CEORobert A. Bradway
Employees३१.५ हजार
Founded१९८०
Headquartersथाउजेन्ड ओक्स, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
Sector-
Websiteamgen.com